These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27113251)

  • 1. Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib.
    Branco B; Metsu D; Dutertre M; Marchou B; Delobel P; Recher C; Martin-Blondel G
    Ann Hematol; 2016 Jun; 95(7):1207-9. PubMed ID: 27113251
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal Disseminated Tuberculosis and Concurrent Disseminated Cryptococcosis in a Ruxolitinib-treated Patient with Primary Myelofibrosis: A Case Report and Literature Review.
    Ogai A; Yagi K; Ito F; Domoto H; Shiomi T; Chin K
    Intern Med; 2022 Apr; 61(8):1271-1278. PubMed ID: 34565769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature.
    Tsukamoto Y; Kiyasu J; Tsuda M; Ikeda M; Shiratsuchi M; Ogawa Y; Yufu Y
    Intern Med; 2018 May; 57(9):1297-1300. PubMed ID: 29279479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelofibrosis: An unusual presentation of disseminated tuberculosis.
    Sharma N; Bikkina SV; Gupta M; Tahlan A
    Int J Mycobacteriol; 2020; 9(2):216-219. PubMed ID: 32474548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruxolitinib and tuberculosis: A case report with brief review.
    Tiwari N; Singh A; Singh B; Verma SP; Tripathi AK
    Indian J Tuberc; 2022 Jul; 69(3):354-358. PubMed ID: 35760486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis.
    Cerchione C; Peluso I; Nappi D; Pareto AE; Picardi M; Martinelli V; Pane F
    Ann Hematol; 2017 Apr; 96(4):697-699. PubMed ID: 28197723
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of chronic kidney failure with thrombotic thrombocytopenic purpura due to miliary tuberculosis].
    Iwamatsu H; Teramura T; Kikuchi M; Yoshida K
    Nihon Naika Gakkai Zasshi; 1998 Feb; 87(2):335-7. PubMed ID: 9549329
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermittent chemotherapy for miliary tuberculosis in children.
    Anadol D; Kiper N; Göçmen A; Ozçelik U
    Turk J Pediatr; 1999; 41(1):53-9. PubMed ID: 10770676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib.
    Andrei M; Sindhu H; Wang JC
    Leuk Lymphoma; 2015 Feb; 56(2):524-6. PubMed ID: 24893800
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).
    Mascarenhas J; Marcellino BK; Lu M; Kremyanskaya M; Fabris F; Sandy L; Mehrotra M; Houldsworth J; Najfeld V; El Jamal S; Petersen B; Moshier E; Hoffman R
    Leuk Res; 2020 Jan; 88():106272. PubMed ID: 31778911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge.
    Palandri F; Polverelli N; Catani L; Vianelli N
    Ann Hematol; 2015 Mar; 94(3):519-20. PubMed ID: 25172457
    [No Abstract]   [Full Text] [Related]  

  • 12. Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis.
    Guglielmelli P; Rotunno G; Bogani C; Mannarelli C; Giunti L; Provenzano A; Giglio S; Squires M; Stalbovskaya V; Gopalakrishna P; Vannucchi AM;
    Br J Haematol; 2016 Jun; 173(6):938-40. PubMed ID: 26303809
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis.
    Gowin K; Kosiorek H; Dueck A; Mascarenhas J; Hoffman R; Reeder C; Camoriano J; Tibes R; Gano K; Palmer J; Mesa R
    Leuk Res; 2017 Sep; 60():31-35. PubMed ID: 28646676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.
    Komatsu N; Kirito K; Shimoda K; Ishikawa T; Ohishi K; Ohyashiki K; Takahashi N; Okada H; Amagasaki T; Yonezu T; Akashi K
    Int J Hematol; 2017 Mar; 105(3):309-317. PubMed ID: 27832516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis.
    Caocci G; Ghiani S; Mocci C; La Nasa G
    Acta Haematol; 2018; 139(3):164-165. PubMed ID: 29597187
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful dialysis treatment of rifampicin-induced acute kidney failure in a 79-year-old patient with tuberculosis].
    Kirsten D; Schmidt U; Marx M; Lutterberg K; Roth G
    Z Erkr Atmungsorgane; 1982; 159(3):303-8. PubMed ID: 7184224
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis.
    Chen YH; Lee CH; Pei SN
    Leuk Lymphoma; 2015 May; 56(5):1528-9. PubMed ID: 25213182
    [No Abstract]   [Full Text] [Related]  

  • 18. Ruxolitinib treatment improves muscle mass in patients with myelofibrosis.
    Lucijanic M; Galusic D; Soric E; Sedinic M; Cubela M; Huzjan Korunic R; Pejsa V; Kusec R
    Ann Hematol; 2021 Apr; 100(4):1105-1106. PubMed ID: 32870367
    [No Abstract]   [Full Text] [Related]  

  • 19. Presence of miliary tubercles associated with myelofibrosis in bone marrow biopsy. A case report.
    Shih LY; Wu CS; Chen L
    Taiwan Yi Xue Hui Za Zhi; 1981 Mar; 80(3):369-74. PubMed ID: 6942122
    [No Abstract]   [Full Text] [Related]  

  • 20. About an unusual systemic disorder: report of a cryptic miliary tuberculosis.
    D'odemont JP; Montiel V; Philippart I
    Acta Clin Belg; 2005; 60(1):36-40. PubMed ID: 15981704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.